معرفی
Clara David is a researcher at the University of Namur, actively contributing to the Clinical Pharmacology Research Group. Her work focuses on neutralizing antibodies, vaccine development, and coagulation disorders in pediatric liver disease.
- Active in clinical pharmacology and immunology research
- Collaborates with multidisciplinary teams on thrombomodulin resistance and SARS-CoV-2 immunity
Her research aligns with SDG 3 (Good Health and Well-being), particularly in improving vaccine efficacy and understanding post-transplantation hemostasis.
Recent research output includes studies on:
- Neutralizing antibodies against emerging SARS-CoV-2 variants
- Long-term immune response to bivalent mRNA vaccines
- Hemostatic challenges in children with cirrhosis
Clara David has been featured in media coverage for her contributions to:
- Thrombin receptor dynamics
- Vaccine-induced immunity
- Anticoagulant therapies
۰مقاله منتشرشده
